LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 508

Search options

  1. Article: Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns.

    Lucas, Elisa / Jurado-Pueyo, María / Fortuño, María A / Fernández-Veledo, Sonia / Vila-Bedmar, Rocío / Jiménez-Borreguero, Luis J / Lazcano, Juan J / Gao, Ehre / Gómez-Ambrosi, Javier / Frühbeck, Gema / Koch, Walter J / Díez, Javier / Mayor, Federico / Murga, Cristina

    Biochimica et biophysica acta

    2014  Volume 1842, Issue 12 Pt A, Page(s) 2448–2456

    Abstract: G protein-coupled receptor kinase 2 (GRK2) has recently emerged as a negative modulator of insulin ...

    Abstract G protein-coupled receptor kinase 2 (GRK2) has recently emerged as a negative modulator of insulin signaling. GRK2 downregulation improves insulin sensitivity and prevents systemic insulin resistance. Cardiac GRK2 levels are increased in human heart failure, while genetically inhibiting GRK2 leads to cardioprotection in mice. However, the molecular basis underlying the deleterious effects of GRK2 up-regulation and the beneficial effects of its inhibition in the heart are not fully understood. Therefore, we have explored the interconnections among a systemic insulin resistant status, GRK2 dosage and cardiac insulin sensitivity in adult (9 month-old) animals. GRK2(+/-) mice display enhanced cardiac insulin sensitivity and mild heart hypertrophy with preserved systolic function. Cardiac gene expression is reprogrammed in these animals, with increased expression of genes related to physiological hypertrophy, while the expression of genes related to pathological hypertrophy or to diabetes/obesity co-morbidities is repressed. Notably, we find that cardiac GRK2 levels increase in situations where insulin resistance develops, such as in ob/ob mice or after high fat diet feeding. Our data suggest that GRK2 downregulation/inhibition can help maintain cardiac function in the face of co-morbidities such as insulin resistance, diabetes or obesity by sustaining insulin sensitivity and promoting a gene expression reprogramming that confers cardioprotection.
    MeSH term(s) Animals ; Blotting, Western ; Cardiomegaly/genetics ; Cardiomegaly/metabolism ; Cell Membrane/drug effects ; Cell Membrane/metabolism ; Diet, High-Fat/adverse effects ; Down-Regulation ; G-Protein-Coupled Receptor Kinase 2/genetics ; G-Protein-Coupled Receptor Kinase 2/metabolism ; Gene Expression Profiling/methods ; Glucose Transporter Type 4/metabolism ; Hypoglycemic Agents/pharmacology ; Insulin/pharmacology ; Insulin Resistance/genetics ; Mice, 129 Strain ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Obese ; Myocardium/metabolism ; Obesity/etiology ; Obesity/genetics ; Obesity/metabolism ; Oligonucleotide Array Sequence Analysis ; Phosphorylation/drug effects ; Proto-Oncogene Proteins c-akt/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Time Factors
    Chemical Substances Glucose Transporter Type 4 ; Hypoglycemic Agents ; Insulin ; Slc2a4 protein, mouse ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; Adrbk1 protein, mouse (EC 2.7.11.15) ; G-Protein-Coupled Receptor Kinase 2 (EC 2.7.11.16)
    Language English
    Publishing date 2014-12
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbadis.2014.09.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Phenotyping the obesities: reality or utopia?

    Portincasa, Piero / Frühbeck, Gema

    Reviews in endocrine & metabolic disorders

    2023  Volume 24, Issue 5, Page(s) 767–773

    Abstract: In this thematic issue on phenotyping the obesities, prominent international experts offer an insightful and comprehensive collection of articles covering the current knowledge in the field. In order to actually capture all the polyhedral determinants of ...

    Abstract In this thematic issue on phenotyping the obesities, prominent international experts offer an insightful and comprehensive collection of articles covering the current knowledge in the field. In order to actually capture all the polyhedral determinants of the diverse types of obesity, the granularity of the phenotypic information acquired must be expanded in the context of a personalized approach. Whilst the use of precision medicine has been successfully implemented in areas like cancer and other diseases, health care providers are more reluctant to embrace detailed phenotyping to guide diagnosis, treatment and prevention in obesity. Given its multiple complex layers, phenotyping necessarily needs to go beyond the multi-omics approach and incorporate all the diverse spheres that conform the reality of people living with obesity. Potential barriers, difficulties, roadblocks and opportunities together with their interaction in a syndemic context are analyzed. Plausible lacunae are also highlighted in addition to pointing to the need of redefining new conceptual frameworks. Therefore, this extraordinary collection of state-ofthe-art reviews provides useful information to both experienced clinicians and trainees as well as academics to steer clinical practice and research in the management of people living with obesity irrespective of practice setting or career stage.
    MeSH term(s) Humans ; Utopias ; Obesity/diagnosis
    Language English
    Publishing date 2023-08-04
    Publishing country Germany
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2185718-0
    ISSN 1573-2606 ; 1389-9155
    ISSN (online) 1573-2606
    ISSN 1389-9155
    DOI 10.1007/s11154-023-09829-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The obesity syndemic in the European community: towards a systems thinking approach for preventive policies.

    Frühbeck, Gema / Busetto, Luca / Carbone, Federico

    European heart journal

    2024  

    Language English
    Publishing date 2024-02-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehae066
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease.

    Polyzos, Stergios A / Frühbeck, Gema / Kiortsis, Dimitrios N

    Current pharmaceutical design

    2024  Volume 29, Issue 41, Page(s) 3263–3265

    MeSH term(s) Humans ; Non-alcoholic Fatty Liver Disease/drug therapy ; Glucagon-Like Peptide 1 ; Insulin ; Peptides/pharmacology ; Peptides/therapeutic use ; Diabetes Mellitus, Type 2 ; Glucagon-Like Peptide-1 Receptor ; Hypoglycemic Agents
    Chemical Substances Glucagon-Like Peptide 1 (89750-14-1) ; Insulin ; Peptides ; Glucagon-Like Peptide-1 Receptor ; Hypoglycemic Agents
    Language English
    Publishing date 2024-01-10
    Publishing country United Arab Emirates
    Document type Editorial
    ZDB-ID 1304236-1
    ISSN 1873-4286 ; 1381-6128
    ISSN (online) 1873-4286
    ISSN 1381-6128
    DOI 10.2174/0113816128279822231211101522
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cagrilintide plus semaglutide for obesity management.

    Becerril, Sara / Frühbeck, Gema

    Lancet (London, England)

    2021  Volume 397, Issue 10286, Page(s) 1687–1689

    MeSH term(s) Glucagon-Like Peptides ; Humans ; Islet Amyloid Polypeptide ; Obesity Management
    Chemical Substances Islet Amyloid Polypeptide ; semaglutide (53AXN4NNHX) ; Glucagon-Like Peptides (62340-29-8) ; cagrilintide (AO43BIF1U8)
    Language English
    Publishing date 2021-04-22
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(21)00944-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Relevance of body composition in phenotyping the obesities.

    Salmón-Gómez, Laura / Catalán, Victoria / Frühbeck, Gema / Gómez-Ambrosi, Javier

    Reviews in endocrine & metabolic disorders

    2023  Volume 24, Issue 5, Page(s) 809–823

    Abstract: Obesity is the most extended metabolic alteration worldwide increasing the risk for the development of cardiometabolic alterations such as type 2 diabetes, hypertension, and dyslipidemia. Body mass index (BMI) remains the most frequently used tool for ... ...

    Abstract Obesity is the most extended metabolic alteration worldwide increasing the risk for the development of cardiometabolic alterations such as type 2 diabetes, hypertension, and dyslipidemia. Body mass index (BMI) remains the most frequently used tool for classifying patients with obesity, but it does not accurately reflect body adiposity. In this document we review classical and new classification systems for phenotyping the obesities. Greater accuracy of and accessibility to body composition techniques at the same time as increased knowledge and use of cardiometabolic risk factors is leading to a more refined phenotyping of patients with obesity. It is time to incorporate these advances into routine clinical practice to better diagnose overweight and obesity, and to optimize the treatment of patients living with obesity.
    MeSH term(s) Humans ; Diabetes Mellitus, Type 2/diagnosis ; Waist Circumference ; Obesity ; Body Mass Index ; Adiposity ; Body Composition ; Risk Factors
    Language English
    Publishing date 2023-03-17
    Publishing country Germany
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2185718-0
    ISSN 1573-2606 ; 1389-9155
    ISSN (online) 1573-2606
    ISSN 1389-9155
    DOI 10.1007/s11154-023-09796-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Towards an adiposity-related disease framework for the diagnosis and management of obesities.

    Perdomo, Carolina M / Avilés-Olmos, Icíar / Dicker, Dror / Frühbeck, Gema

    Reviews in endocrine & metabolic disorders

    2023  Volume 24, Issue 5, Page(s) 795–807

    Abstract: Obesity is a complex disease that relapses frequently and associates with multiple complications that comprise a worldwide health priority because of its rising prevalence and association with numerous complications, including metabolic disorders, ... ...

    Abstract Obesity is a complex disease that relapses frequently and associates with multiple complications that comprise a worldwide health priority because of its rising prevalence and association with numerous complications, including metabolic disorders, mechanic pathologies, and cancer, among others. Noteworthy, excess adiposity is accompanied by chronic inflammation, oxidative stress, insulin resistance, and subsequent organ dysfunction. This dysfunctional adipose tissue is initially stored in the visceral depot, overflowing subsequently to produce lipotoxicity in ectopic depots like liver, heart, muscle, and pancreas, among others. People living with obesity need a diagnostic approach that considers an exhaustive pathophysiology and complications assessment. Thus, it is essential to warrant a holistic diagnosis and management that guarantees an adequate health status, and quality of life. The present review summarizes the different complications associated with obesity, at the same time, we aim to fostering a novel framework that enhances a patient-centered approach to obesity management in the precision medicine era.
    MeSH term(s) Humans ; Adiposity ; Quality of Life ; Obesity/diagnosis ; Obesity/therapy ; Obesity/complications ; Adipose Tissue/metabolism ; Inflammation/metabolism ; Insulin Resistance/physiology
    Language English
    Publishing date 2023-05-10
    Publishing country Germany
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2185718-0
    ISSN 1573-2606 ; 1389-9155
    ISSN (online) 1573-2606
    ISSN 1389-9155
    DOI 10.1007/s11154-023-09797-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Bariatric and metabolic surgery: a shift in eligibility and success criteria.

    Frühbeck, Gema

    Nature reviews. Endocrinology

    2015  Volume 11, Issue 8, Page(s) 465–477

    Abstract: The obesity epidemic, combined with the lack of available and effective treatments for morbid obesity, is a scientific and public health priority. Worldwide, bariatric and metabolic surgeries are increasingly being performed to effectively aid weight ... ...

    Abstract The obesity epidemic, combined with the lack of available and effective treatments for morbid obesity, is a scientific and public health priority. Worldwide, bariatric and metabolic surgeries are increasingly being performed to effectively aid weight loss in patients with severe obesity, as well as because of the favourable metabolic effects of the procedures. The positive effects of bariatric surgery, especially with respect to improvements in type 2 diabetes mellitus, have expanded the eligibility criteria for metabolic surgery to patients with diabetes mellitus and a BMI of 30-35 kg/m(2). However, the limitations of BMI, both in the diagnosis and follow-up of patients, need to be considered, particularly for determining the actual adiposity and fat distribution of the patients following weight loss. Understanding the characteristics shared by bariatric and metabolic surgeries, as well as their differential aspects and outcomes, is required to enhance patient benefits and operative achievements. For a holistic approach that focuses on the multifactorial effects of bariatric and metabolic surgery to be possible, a paradigm shift that goes beyond the pure semantics is needed. Such a shift could lead to profound clinical implications for eligibility criteria and the definition of success of the surgical approach.
    MeSH term(s) Bariatric Surgery/methods ; Bariatric Surgery/standards ; Diabetes Mellitus, Type 1/surgery ; Humans ; Metabolic Diseases/surgery ; Obesity/surgery ; Treatment Outcome
    Language English
    Publishing date 2015-08
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2489381-X
    ISSN 1759-5037 ; 1759-5029
    ISSN (online) 1759-5037
    ISSN 1759-5029
    DOI 10.1038/nrendo.2015.84
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Benefits of Bariatric Surgery Prior to SARS-CoV-2 Infection in Modulating the Response to COVID-19.

    Landecho, Manuel F / Frühbeck, Gema

    Obesity (Silver Spring, Md.)

    2020  Volume 29, Issue 1, Page(s) 19

    MeSH term(s) Bariatric Surgery ; COVID-19 ; Humans ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-12-03
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2230457-5
    ISSN 1930-739X ; 1071-7323 ; 1930-7381
    ISSN (online) 1930-739X
    ISSN 1071-7323 ; 1930-7381
    DOI 10.1002/oby.23059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The healthy weight debate: does it apply to weight loss in obesity?

    Frühbeck, Gema

    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

    2014  Volume 60 Suppl 1, Page(s) 29–32

    MeSH term(s) Body Composition ; Body Weight ; Humans ; Obesity/therapy ; Weight Loss
    Language English
    Publishing date 2014-01-31
    Publishing country Spain
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1469349-5
    ISSN 1579-2021 ; 0211-2299 ; 1575-0922
    ISSN (online) 1579-2021
    ISSN 0211-2299 ; 1575-0922
    DOI 10.1016/s1575-0922(13)70023-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top